New cancer clinical trial: Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer

Published on: March 19, 2019 at 06:00PM
Condition:   Colorectal Cancer
Interventions:   Drug: TMZ;   Drug: Nivolumab
Sponsors:   Memorial Sloan Kettering Cancer Center;   Bristol-Myers Squibb
Recruiting